Perceptions and Representations of Cancer Chemotherapy (chemotherapy)

July 27, 2016 updated by: University Hospital, Montpellier
Qualitative study on data from interviews such patients, relatives and doctors involved in the implementation of cancer care. Framework type of method using grounded theory

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The word chemotherapy itself, because it belongs to the secular knowledge and therefore Doxa is a hard word, which stores what it is stable, common and therefore impersonal. It has the properties of a symbol, that is to say that joint several meanings, some of which are contradictory.

The objective of the research:

To determine the perceptions and representations of chemotherapy, its physical impacts, psychological and relational.

To qualitatively compare the performances of chemotherapy as it has an end as scheduled for adjuvant chemotherapy, or endless precise as in the palliative chemotherapy

Study Type

Observational

Enrollment (Actual)

75

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

  • 30 major Patients with lung cancer requiring chemotherapy either as palliative or adjuvant as surgical treatment
  • 30 significant others (relatives) major applicant lung cancer patients chemotherapy either palliation or as adjuvant to surgery
  • 15 Doctors oncologists performing either chemotherapy as palliative or adjuvant as surgical treatment

Description

Inclusion Criteria:

  • 30 major Patients with lung cancer requiring chemotherapy either as palliative or adjuvant as surgical treatment
  • 30 significant others (relatives) major applicant lung cancer patients chemotherapy either palliation or as adjuvant to surgery
  • 15 Doctors oncologists performing either chemotherapy as palliative or adjuvant as surgical treatment

Exclusion Criteria:

  • NA

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients requiring lung cancer chemotherapy
30 major Patients with lung cancer requiring chemotherapy either as palliative or adjuvant as surgical treatment having a semi-structured interview conducted by a clinical psychologist
Other: semi-structured interview conducted by a clinical psychologist
semi-structured interview conducted by a clinical psychologist
Family of lung cancer patients receiving chemotherapy
30 Family of lung cancer patients receiving chemotherapy having a semi-structured interview conducted by a clinical psychologist
Other: semi-structured interview conducted by a clinical psychologist
semi-structured interview conducted by a clinical psychologist
doctors caring for lung cancer patients receiving chemotherapy
15 doctors caring for lung cancer patients receiving chemotherapy 15 have a semi-structured interview conducted by a psychiatrist specialized in psycho-oncology
Other: semi-structured interview conducted by a psychiatrist specialized in psycho-oncology
semi-structured interview conducted by a psychiatrist specialized in psycho-oncology

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The semi-structured interview
Time Frame: 1 day (day of inclusion)
The interview will be analyzed in a framework type of method (grounded theory) in accordance with the guidelines coreq.
1 day (day of inclusion)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Montpellier

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2015

Primary Completion (Actual)

December 1, 2015

Study Completion (Actual)

December 1, 2015

Study Registration Dates

First Submitted

June 30, 2016

First Submitted That Met QC Criteria

July 27, 2016

First Posted (Estimate)

August 1, 2016

Study Record Updates

Last Update Posted (Estimate)

August 1, 2016

Last Update Submitted That Met QC Criteria

July 27, 2016

Last Verified

March 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • RECHMPL16_0208

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lung Cancer

Clinical Trials on semi-structured interview conducted by a clinical psychologist

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Estonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe